Navigation Links
CareFusion Reports First Quarter Fiscal 2012 Results
Date:11/7/2011

business increased organically and due to the August 2011 acquisition of Rowa, a Germany-based company specializing in robotic medication storage and retrieval systems for retail and hospital pharmacies. Sales of Infusion Systems increased as a result of core business growth primarily in the dedicated disposable product volumes. These increases were partially offset by a decrease in Respiratory Technologies sales, primarily due to lower sales of ventilators in Western Europe. Segment profit increased 29 percent to $88 million, and adjusted segment profit increased 6 percent to $95 million, both of which were negatively impacted by the $12 million increase in the company's recall reserves.

Procedural SolutionsRevenue for the Procedural Solutions segment decreased 2 percent on a reported basis to $335 million, or 4 percent on a constant currency basis, driven by the loss of sales from divesting the company's OnSite Services business in March 2011. This decrease was partially offset by an increase in sales in the company's Infection Prevention business. Net of the OnSite Services business divestiture, segment revenues grew 1 percent in the first quarter compared to the prior year period. Segment profit increased 82 percent to $20 million due to margin expansion and strong expense controls, and adjusted segment profit decreased 14 percent to $24 million, primarily driven by the divestiture of the OnSite Services business.

Fiscal 2012 Outlook CareFusion is reiterating financial guidance for the fiscal year ending June 30, 2012. The company continues to expect fiscal 2012 revenues to grow 3 to 5 percent on a constant currency basis compared to fiscal 2011 revenue of $3.53 billion and for adjusted diluted earnings per share to be in the range of $1.80 to $1.90. The guidance is based on an assumed diluted weighted average outstanding share count of approximately 226 million.

Conference CallCareFusion will host a conference
'/>"/>

SOURCE CareFusion
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. ERT Closes the Acquisition of the Research Services Division of CareFusion Corporation
2. Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011
3. InterMune Reports Third Quarter 2011 Financial Results and Business Highlights
4. Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results
5. Optimer Pharmaceuticals Reports Third Quarter 2011 Financial Results
6. Caliper Life Sciences Reports Third Quarter 2011 Results
7. Neurocrine Biosciences Reports Third Quarter 2011 Results
8. United Therapeutics Corporation Reports Third Quarter 2011 Financial Results
9. Sangamo BioSciences Reports Third Quarter 2011 Financial Results
10. Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
11. ReportsnReports: Depression Therapeutics Market to Reach $10.9 Billion by 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015   Neuraltus Pharmaceuticals, Inc. , a ... groundbreaking drugs to treat neurodegenerative diseases such as ... Robert G. Miller , M.D., Director of the Forbes ... Pacific Medical Center in San Francisco, has been awarded ... million to help fund a Phase 2 clinical ...
(Date:7/1/2015)... ... July 01, 2015 , ... Apex Therapeutics announced today that company CEO, ... PA. , The presentation took place on Tuesday, June 16 and provided ... development of APX3330 for the treatment of pancreatic cancer. A copy of the ...
(Date:6/30/2015)... CALGARY , June 30, 2015 /PRNewswire/ - ... ("Shareholders") of common shares of Resverlogix have approved ... to Eastern Capital Limited of 5,600,000 units at ... Private Placement"), each unit being comprised of one ... for aggregate proceeds of approximately CAD$15 million; and ...
(Date:6/30/2015)... ... June 30, 2015 , ... uBiome and OpenBiome Partner for ... of fecal microbiota transplantation in C. difficile patients. , SAN FRANCISCO, uBiome and ... fecal microbiota transplantation (FMT) as a treatment for Clostridium difficile infections (C. diff). ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3
... looking for new directions in technology business are heading to ... the traditional conference Camp WorldWIT , starting Thursday ... and two full days of seminars and workshops. , ,"Everybody ... and the things that you're doing physically make a big ...
... from attending the 2nd Annual Future of Work World ... business, government and community economic development came together to envision ... real. , ,The historic Society Hill district and Independence Mall ... attractive mix of the old, the restored and the new. ...
... Milwaukee Norlight Telecommunications Inc. plans ... fiberoptic cable. , ,The company says it operates 3,800 ... miles more later this year. The Illinois expansion plans ... based near Milwaukee and provides wholesale network access to ...
Cached Biology Technology:Women in technology confab comes to Wisconsin 2The future of work is now 2The future of work is now 3The future of work is now 4
(Date:6/17/2015)... , Deutschland und GERMANTOWN, Maryland ... Investigator ®   Produktlinie mit DNA-Tests ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... neue STR-Testkits der Produktlinie Investigator ... in den Markt eingeführt. Die neuen Kits zur Erstellung ...
(Date:6/16/2015)... June 16, 2015  With the increasing number and ... a top concern. The recent compromise of Federal ... for strong authentication within government agencies. HYPR ... one-time password (OTP) authenticator, has been submitted for testing ... Level 3 validation for tamper proofing. ...
(Date:6/15/2015)... 15, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, announces that its leading payment security ... at Digital Experience! @ NYC June 18th. Digital ... latest innovation in technology to over 300 of the top ... the Metropolitan Pavilion in New York City ...
Breaking Biology News(10 mins):QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
... discovered dozens of potentially beneficial bioactive microorganisms within plants ... so genetically distinct that they may be the first ... 135 endophytes - fungal and bacterial microorganisms living within ... the Rain Forest Expedition and Laboratory course at Yale ...
... small package sizes these days, presumably to help consumers ... Journal of Consumer Research found that people actually ... packages than large ones. And smaller packages make people ... first place. Authors Rita Coelho do Vale (Technical ...
... to access 3D images of biomacromolecules underlying biological ... to provide the understanding of biomacromolecule structures, a ... resource by linking written information and three-dimensional structural ... BioMed Central,s open access journal Genome Biology, displays ...
Cached Biology News:Yale undergrads' Amazon trip yields a treasure trove of diversity 2Pay attention! Small packages may lead to overeating 2
...
Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
BD Biocoat Matrigel Matrix Thin Layer 35 mm Culture Dishes...
BD Primaria 35 mm Cell Culture Dish with Easy-Grip design, surface-modified polystyrene for enhanced cell culture. (20/sp, 200/ca) Packaging: 20 / sleeve, 500 / case ...
Biology Products: